Lazard Asset Management LLC Cuts Position in Edwards Lifesciences Co. (NYSE:EW)
Lazard Asset Management LLC decreased its holdings in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 16.6% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 4,586 shares of the medical research company’s stock after selling 913 shares during the period. Lazard Asset Management LLC’s holdings in Edwards […]
